- Home
- About Us
- Service
- Application
- Technology
- Resource
- Contact Us
HapOnco® Hereditary Cancer Gene Testing
HapOnco® Hereditary Cancer Gene Testing
HapOnco® Hereditary Colorectal Cancer
Product Introduction
Hereditary cancer refers to a category of tumors that have heritable characteristics, accounting for 5 - 10% of all tumors. When an individual carries a mutated gene, the risk of developing cancer is significantly increased. If cancer is detected early and timely prevention and treatment are carried out, a better prognosis can be achieved. HaploX independently developed the HapOnco® Hereditary Cancer Gene Testing product, which can detect genes related to the heritability of tumors and provide guidance for clinical diagnosis and the development of treatment plans.
Product Content
Applicable Population
✅ People with a Family History of Cancer
- · Multiple relatives in the same family are affected by the same or related types of cancer;
- · The age of cancer onset in relatives is significantly earlier than that in the general population (usually ≤50 years);
- · An individual is diagnosed with two or more primary cancers;
- · Bilateral tumors occur in paired organs (e.g., bilateral breast cancer, bilateral renal cell carcinoma).
✅ Patients with a Confirmed Cancer Diagnosis
- · The age of own cancer onset is significantly earlier than the average for the same type of cancer;
- · Multiple, recurrent, or cross-system cancers are present in the individual or family;
- · Desire to clarify whether the own cancer is associated with genetic factors.
✅ Individuals with Chronic Diseases or Abnormal Physical Signs
- · Recurrent or unexplained chronic diseases, such as: chronic pancreatitis; recurrent breast hyperplasia, ovarian cysts; multiple polyps or nodules of unknown cause; long disease course with limited effect of conventional treatment.
